Legend Biotech is a fully integrated cell therapy company with targeted expertise, focused on developing innovative cellular therapies to improve the lives of patients worldwide. The company was founded in 2014 and has since become a global, commercial-stage company driven by a passion for patients.

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

COM:LEGENDBIOTECH

Legend Biotech

Last Close

56.71

30/08 20:00

Market Cap

10.54B

Beta: -

Volume Today

516.25K

Avg: -

Analysis Not Available